| |
|
|
|
Synthetic Biologics Inc.  
|
|
0.7125 -0.013 (-0.02%) |
03-22 16:00 |
|
Open: |
0.7036 |
Pre close: |
0.725 |
Target:
|
0.89 
|
|
High: |
0.7204 |
Low: |
0.703 |
Resistance:
|
0.76
0.85
|
|
Volume: |
234,177 |
Market Cap: |
11M |
Support:
|
0.61
0.51
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.75
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
0.69 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
0.69 |
Stochastic Oscillator |
%K(14,3):
|
47.80 |
|
MA(250): |
4.05 |
%D(3): |
57.36 |
|
Average Volume(K) |
3-Month: |
34633
|
52-Week |
High:
|
13.30 |
|
10-Days: |
76605 |
Low: |
0.51 |
|
RSI |
RSI(14):
|
52.22 |
Change(%): |
-94.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.010 |
Return on Equity (ttm) |
-515.5 |
Shares Out. (M) |
15.48 |
|
EPS Est. Current Year |
-0.170 |
Return on Assets (ttm) |
-103.3 |
Shares Float (M) |
9.97 |
|
EPS Est. Next Year |
-0.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.30 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.00 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
383 |
|
Book Value (p.s.) |
1.110 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.18 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.64 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-17.28 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-14.75 |
P/CF |
-0.64 |
|
|
|
|
|
|
